
ASTRRA by A. S. Thomas, Inc. | ASTRRA OneTouch Automatic …
Since 2008 ASTRRA has been revolutionizing packaging automation. Based on industry standard wireless communications protocols, ASTRRA is a distributed control system which eliminates cumbersome and expensive point-to-point control wiring to a central PLC. Instead, only one inexpensive 24VDC bus is required along the length of the conveyor.
ASCO热评丨朱丽教授:ASTRRA研究8年结果公布,绝经前乳腺癌 …
2022年6月17日 · 2022年asco大会上,astrra研究8年随访结果公布,再次证实了tam+ofs可以提高绝经前乳腺癌患者的无病生存。 《肿瘤瞭望》特邀 上海交通大学医学院附属第一人民医院王玮医生、朱丽教授对该项研究结果进行…
Adding Ovarian Suppression to Tamoxifen for Premenopausal
2023年8月23日 · Purpose: To determine the updated long-term outcomes of the Addition of Ovarian Suppression to Tamoxifen in Young Women With Hormone-Sensitive Breast Cancer Who Remain Premenopausal or Regain Vaginal Bleeding After Chemotherapy (ASTRRA) trial.
Adding Ovarian Suppression to Tamoxifen for Premenopausal …
2023年8月22日 · In this study, we present the results from the post-trial follow-up of the ASTRRA trial, which assessed the disease-free survival (DFS) and overall survival (OS) to evaluate the efficacy of adding 2 years of ovarian function suppression (OFS) to tamoxifen (TAM) in patients with hormone receptor–positive breast cancer who remain in a ...
Astrra - YouTube
Monster Roblox Horror Game PLAY NOW: https://www.roblox.com/games/18540132... I'm Astrra and I make fun tutorials, gameplay, and more!
8年结果公布,绝经前乳腺癌患者卵巢去势获益仍显著 - 知乎
astrra是一项开放标签、前瞻性、随机、多中心研究者发起的 iii期临床研究 。 研究入组的≤45岁绝经前ER+乳腺癌患者, 与SOFT研究化疗组的入组人群基本相似:中位年龄(40岁)、淋巴结阳性率(55%比57%)、HER2阳性率(14%比19%)。
Meeting Abstract: 2022 ASCO Annual Meeting I - ASCO Publications
2022年6月2日 · Background: Addition of Ovarian Suppression to Tamoxifen in Young Women With Hormone-Sensitive Breast Cancer Who Remain Premenopausal or Regain Vaginal Bleeding After Chemotherapy (ASTRRA) trial, at 63 months median follow-up, showed that the addition of 2 years of ovarian function suppression (OFS) to Tamoxifen (TAM) significantly improved ...
吕鹏威教授:从ASTRRA研究8年随访全文发表,再看绝经前HR+乳 …
2023年10月16日 · ASTRRA是一项由研究者发起的、开放标签、前瞻性、随机、多中心、Ⅲ期试验,该研究从韩国35所医疗机构入组I~III期绝经前≤45岁、HR+且接受过根治性切除术和(新)辅助化疗的患者。 在登记时根据血清卵泡刺激素(FSH)水平评估卵巢功能,对血清FSH水平在30mIU/ml以上患者进行2年内每6个月一次的卵巢功能评估,卵巢功能恢复指FSH水平低于30mIU/ml或阴道出血。 经筛选,1282例处于绝经前状态的患者随机分配至在5年TAM标准治 …
oneTouch | ASTRRA by A. S. Thomas, Inc.
ASTRRA’s oneTouch automatic changeover system can handle all your rail and machine changeover adjustments. Since 2008 ASTRRA has been revolutionizing packaging automation. All you have to do is is touch the package image. 100 mm Actuator with Guide rail stiffener. Box Conveyor Incline. Sequence oriented changeover. Full Traceability.
Products | ASTRRA by A. S. Thomas, Inc.
ASTRRA is a product of A. S. Thomas, Inc. The ASTRRA change over process and products are patented and patent pending.